Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity
Sacha J Howell, Elizabeth Anderson, Tom Hunter, Gillian Farnie…Volume:
10
Language:
english
DOI:
10.1186/bcr2129
Date:
August, 2008
File:
PDF, 2.43 MB
english, 2008